Lifecore Biomedical, Inc. De (LFCR) Consolidated Net Income (2010 - 2024)

Lifecore Biomedical's Consolidated Net Income history runs 15 years deep, the most recent figure standing at $3000.0 for Q2 2024.

• In Q2 2024, Consolidated Net Income rose 100.13% year-over-year to $3000.0; the TTM figure through Feb 2025 stood at $3000.0 (down 99.22% YoY), while the FY2024 annual figure was $2.7 million, up 107.59% from the prior year.
• Consolidated Net Income was $3000.0 for Q2 2024 at Lifecore Biomedical, down from $847000.0 in the prior quarter.
• In the past five years, Consolidated Net Income ranged from a high of $1.8 million in Q3 2023 to a low of -$51.6 million in Q2 2022.
• Historically, Consolidated Net Income has averaged -$9.7 million across 5 years, with a median of -$3.2 million in 2020.
• The sharpest annual moves came in 2022 and 2023: Consolidated Net Income plunged 2376.79% in 2022, then soared 143.44% in 2023.
• A 5-year view of Consolidated Net Income shows it stood at -$3.2 million in 2020, then tumbled by 1323.38% to -$46.0 million in 2021, then jumped by 92.17% to -$3.6 million in 2022, then jumped by 99.33% to -$24000.0 in 2023, then jumped by 112.5% to $3000.0 in 2024.
• The last three Consolidated Net Income figures came in at $3000.0 (Q2 2024), $847000.0 (Q1 2024), and -$24000.0 (Q4 2023), per Business Quant data.